Fujifilm has declared its intention to sue Xerox for damages, saying the latter had “no legal right” to unilaterally pull out of the planned merger deal, reported Bloomberg.
Fujifilm plans to file a lawsuit as soon as possible, President Kenji Sukeno said Friday, May 18, in his first public comments days after the American office products company called off the deal in a settlement with activist shareholders Carl Icahn and Darwin Deason. Still, Fujifilm would also consider any new offer from Xerox, Sukeno said.
“The contract that ties the two companies together is still valid,” Sukeno said at a briefing in Tokyo to announce the company’s financial results. “We will push for the legality of it. There was a legal contract that everyone agreed on, and after that a few shareholders wanted to put a stop to it.”
Fujifilm last week disputed Xerox’s “unilateral decision” to scrap a plan for the Japanese company to take control of the once-iconic American office equipment supplier. Icahn and Deason, two of the biggest shareholders who argued the deal undervalued Xerox, succeeded in their bid to stymie the transaction and push out the American company’s chief executive officer.
Full Content: Bloomberg
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
UK Government Suffers Third Successive Defeat on Data (Use and Access) Bill
May 20, 2025 by
CPI
Sex Toy Retailer Says Google Breaches EU Digital Market Rules
May 20, 2025 by
CPI
Latham & Watkins Expands Brussels Antitrust Team
May 20, 2025 by
CPI
Brazil’s Antitrust Watchdog Expected to Approve Pet Retail Merger Without Conditions
May 20, 2025 by
CPI
EU and UK Finalize Deal to Strengthen Antitrust Cooperation
May 20, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas